(Total Views: 492)
Posted On: 06/11/2020 10:10:09 AM
Post# of 72436
![Avatar](https://investorshangout.com/images/ProfileImages/no_avatar_available.jpg)
Re: Jim Vernon #64921
From 2/24 PR
Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants.
Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Leo Took The Money and Ran